- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hologic, Del Global strike DR deal
Del Global has licensed the rights and trademarks to digital radiography systems originally developed, manufactured, and marketed by Hologic. The agreement between the two companies paves the way for Del Global to begin manufacturing the
Del Global has licensed the rights and trademarks to digital radiography systems originally developed, manufactured, and marketed by Hologic. The agreement between the two companies paves the way for Del Global to begin manufacturing the direct-to-digital general radiography systems under the Epex, Epex ER, DR1000, Omniflex, and Radex brand names. Hologic will support the transfer of manufacturing from its Bedford, MA, facility to a Del facility in Chicago. Also in collaboration with Del, Hologic will provide ongoing service support to customers, as well as its DirectRay detector for integration into Del's finished products. The licensing agreement reflects a strategic shift by Hologic management away from manufacturing finished digital radiography equipment for sale to end users in favor of supplying digital detectors to OEMs.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
